Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. AIkido Pharma Inc.:

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

MARCH 3, 2022

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will host its Europe Regional Event in Prague on March 5 and 6, 2022.

Events 52

Events Supply Chain Marijuana Hemp 52

Cannabis Law Report

MAY 18, 2021

BONG SCORE We apply our entirely subjective bong score to each event 1 Don’t Bother Unless You Need A… Read More.

Data 93

Data Business Events Cannabis 93

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

NOVEMBER 26, 2019

New Frontier Data is looking to partner with other African nations and deliver similar market assessments and implementation studies, fostering responsible practices and clear understanding of potential socioeconomic impacts of hemp and/or cannabis legalization in traditionally agro-based Sub-Saharan economies.

Data 59

Data Cultivation Hemp Research and Development 59

SpeedWeed

JULY 18, 2021

All across the US, lawmakers are scrambling to pass laws that would cap the strength of high-potency cannabis concentrates, arguing that high THC levels pose a serious health risk. One group used cannabis flower with at least 20 percent THC content and over 0.7

Concentrates 98

Concentrates THC Data CBD 98

SpeedWeed

MARCH 4, 2021

LAS VEGAS, NV (March 4, 2021) – Cannabis Conference (August 24-26, 2021, at the Paris Las Vegas Hotel & Casino) today announces its education program, which includes 45+ sessions within four education tracks that will provide actionable takeaways about the most pressing issues plant-touching businesses currently face in the cannabis industry.

Education 52

Education Events Programs Cultivation 52

Illinois News Joint

JANUARY 5, 2024

The Illinois Department of Agriculture (IDOA) and Division of Cannabis Regulation today issued a compliance alert for cannabis transporters in Illinois. Product cannot be held overnight by licensed cannabis transporters. A transporter agent shall not open a cannabis container.

Compliance 72

Compliance Compliance Agriculture Policy 72

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Illinois News Joint

AUGUST 4, 2023

Headset , a data platform for the cannabis economy, recently released a report that examined the Illinois cannabis market. According to Headset, “This report analyzes detailed data on thousands of products in the Illinois market to determine how it compares to other states. compared to 17.3% nationally.” on June 1, 2023.

Extraction 82

Extraction Data Edibles Cannabis 82

Illinois News Joint

AUGUST 17, 2023

Those outside the cannabis community have used the phrase to belittle. According to a recent report from Headset , a data platform for the cannabis economy, Illinois has a higher representation from Baby Boomer and Gen X generations than other states. For more Illinois cannabis industry news, visit here.

Data 84

Data Events Cannabis Patients 84

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . WHEN: Sept. – 12:00 p.m.

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

SpeedWeed

SEPTEMBER 9, 2021

“This is an extinction event,” Johnny Casali, owner of Huckleberry Hill Farms , a cannabis farm in southern Humboldt County, said over the phone. Casali is referring to a recent wholesale price collapse in California’s outdoor-grown cannabis market. . Data firms like Leaflink have not yet registered a price drop.

Events 52

Events Cultivation Advocacy Data 52

Cannabis Law Report

AUGUST 4, 2021

Prohibition Holdings Ltd (parent company of Prohibition Partners) today announces its 100% acquisition of Business of Cannabis to form the industry’s new leader in media and data as well as the largest B2B audience in cannabis. About Business of Cannabis.

Business 105

Business Data Media Cannabis 105

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

FEBRUARY 24, 2022

This summary includes results for cannabis inspections from April 1, 2019 to March 31, 2020. Conducted to monitor and verify compliance of the licence holder with the requirements of the Cannabis Act and its regulations. Conducted to assess compliance with promotion requirements as defined in the Cannabis Act and its regulations.

Compliance 52

Compliance Compliance Data Safety 52

Veriheal

AUGUST 22, 2023

States legalizing recreational cannabis are seeing an unexpected and significant decrease in mental health treatment admissions. Ortega’s research meticulously analyzed data from ten states where adult-use cannabis has become legal. This downward trend did not apply to a specific demographic.

Treatment 98

Treatment Legalization Policy Recreational 98

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs).

Clinical Trials 52

Clinical Trials Safety Data Patients 52

NORML

MARCH 20, 2019

A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk. Rather, this association may exist because many psychiatric patients are self-medicating with cannabis.

THC 280

THC Data Cannabis Events 280

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

Cannabis Law Report

OCTOBER 10, 2019

They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. The space is open as High Times are hobbling along due to their MedMen mismatch, Politico, Forbes et al have good cannabis content but not for the mass market. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. “Our

Data 40

Data Media Banking Cannabis 40

Cannabis Law Report

AUGUST 27, 2021

We apply our entirely subjective bong score to each event. 8, Webinar: Moving from Leaf to new Central Cannabis Reporting System (CCRS). CCRS will simplify the reporting of cannabis data and will use the state’s existing Secure Access Washington (SAW) system, which is already used by licensees for other state-required purposes.

Data 105

Data Sleep Access Compliance 105

Illinois News Joint

JANUARY 29, 2024

One of those brands with new products is Cannect Wellness , a premium craft cannabis cultivator and product manufacturer. Secret Sauce is a custom blend of premium craft cannabis oil, live resin terpenes, CBG, and CBD. “We Instead, you’ll find only the finest craft cannabis products that showcase our commitment to excellence.”

Terpenes 90

Terpenes Cultivation Education Data 90

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Illinois News Joint

FEBRUARY 2, 2024

The Illinois General Assembly Joint Committee on Administrative Rules (JCAR) today announced adopted amendments to the Cannabis Regulation and Tax Act , effective Jan. For more Illinois cannabis industry news, visit here. To find cannabis-friendly events in Illinois, visit here.

Packaging 87

Packaging Agriculture Data History 87

Cannabis Law Report

SEPTEMBER 9, 2021

According to officials, about one-third or 32 percent of cannabis-related complaints in the county couldn’t be locked gates, fences and other visual obstructions. From November 2022 through February 2023, there will be a review of program activity, data and a report to supervisors. The program will last from May through August 2022.

Compliance 100

Compliance Compliance Programs Events 100

Illinois News Joint

MAY 16, 2023

Illinois is set to switch its cannabis seed-to-sale tracking system after delivering a Notice of Intent to award a contract to a new vendor. Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. including Washington, D.C.,

Seed-To-Sale 70

Seed-To-Sale Supply Chain Data Compliance 70

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Illinois News Joint

JANUARY 5, 2023

The Illinois Department of Public Health (IDPH) today reported December 2022 medical cannabis sales totals. were the most medical cannabis sales since April 2022 ($31,774,180.50). Licensed medical cannabis dispensaries served 65,722 unique patients, who purchased 1,235,762 grams of dry cannabis. ILNJ graphic.

Dispensary 78

Dispensary Patients Retail Cultivation 78

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Illinois News Joint

JANUARY 30, 2023

The Cannabis Regulation Oversight Office (CROO) today announced the launch of its new website. The new CROO website has been designed to be more user friendly and a better comprehensive resource for recreational and medical cannabis in Illinois. For more Illinois cannabis industry news, visit here.

Media 83

Media Data Agriculture Recreational 83

Illinois News Joint

OCTOBER 6, 2023

In May 2023, the Illinois Senate created an omnibus with several cannabis-related items that ultimately failed. For more Illinois cannabis industry news, visit here. To find cannabis-friendly events in Illinois, visit here. For Illinois News Joint reviews, visit here.

Packaging 89

Packaging Data Agriculture History 89

The Joint Blog

APRIL 17, 2020

Cannabis Sativa, a.k.a Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. marijuana” is the one of the most popular illicit substances in the world.

Events 48

Events THC Chronic Pain Sleep 48

Illinois News Joint

DECEMBER 12, 2023

6 and also had been included into the failed cannabis omnibus in May. 3) For cannabis grow operations with 6,000 square feet of canopy or more, all HVAC units must be variable refrigerant flow HVAC units, or other more energy efficient equipment. For more Illinois cannabis industry news, visit here.

Packaging 93

Packaging Data Agriculture History 93

Cannabis Law Report

JUNE 16, 2021

As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105